Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

British Journal of Cancer

Volumn 103, Issue 3, 2010, Pages 391-400

  Xue, A ^a   Scarlett, C J ^a,e   Chung, L ^b   Butturini, G ^c   Scarpa, A ^c   Gandy, R ^a   Wilson, S R ^d   Baxter, R C ^b   Smith, R C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF VERONA   (Italy)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

apolipoproteins; pancreatic adenocarcinoma; proteomics; serum biomarkers

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN C1;

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-I; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; CA-19-9 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ISOFORMS; PROTEOMICS; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955051683     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605764     Document Type: Article

References (40)

1. Ambroise C, McLachlan GJ (2002) Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA 99(10): 6562
2. Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, Selby PJ (2005) Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 51(9): 1637
3. Berger AC, Garcia Jr M, Hoffman JP, Regine WF, Abrams RA, Safran H, Konski A, Benson III AB, MacDonald J, Willett CG (2008) Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol 26(36): 5918
4. Bhattacharyya S, Siegel ER, Petersen GM, Chari ST, Suva LJ, Haun RS (2004) Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia 6(5): 674-686
5. Blanco-Vaca F, Escola-Gil JC, Martin-Campos JM, Julve J (2001) Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res 42(11): 1727-1739
6. Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD (1999) Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J Lipid Res 40(3): 543-555
7. Brown MD, Reeves MJ (2003) Evidence-based emergency medicine/skills for evidence-based emergency care. Interval likelihood ratios: another advantage for the evidence-based diagnostician. Ann Emerg Med 42(2): 292
8. Ehmann M, Felix K, Hartmann D, Schnolzer M, Nees M, Vorderwulbecke S, Bogumil R, Buchler MW, Friess H (2007) Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34(2): 205-214
9. Firpo MA, Gay DZ, Granger SR, Scaife CL, DiSario JA, Boucher KM, Mulvihill SJ (2009) Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen. World J Surg 33(4): 716
10. Gao X, Yuan S, Jayaraman S, Gursky O (2009) Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition. J Mol Biol 387(3): 628
11. Gillard BK, Chen YS, Gaubatz JW, Massey JB, Pownall HJ (2005) Plasma factors required for human apolipoprotein A-II dimerization. Biochemistry 44(2): 471
12. Goncalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, Cubizolles M, Bardou VJ, Houvenaegel G, Jacquemier J, Granjeaud S, Meng XY, Fung ET, Birnbaum D, Maraninchi D, Viens P, Borg JP (2006) Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 25(7): 981
13. Goonetilleke KS, Siriwardena AK (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33(3): 266-270
14. Grote T, Logsdon CD (2007) Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol 23(5): 508
15. Guo J, Wang W, Liao P, Lou W, Ji Y, Zhang C, Wu J, Zhang S (2009) Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci 100(12): 2292
16. Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA, Morgan DL, Denson KD, Prejeant KC, Gusev Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ (2008) Biomarker identification in human pancreatic cancer sera. Pancreas 36(1): 61
17. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3): 839-843
18. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Hirohashi S, Yamada T (2005) Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 65(22): 10613-10622
19. Issaq HJ, Conrads TP, Janini GM, Veenstra TD (2002) Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis 23(17): 3048-3061
20. Jin Y, Manabe T (2005) Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry. Electrophoresis 26(14): 2823
21. Kawai S, Suzuki K, Nishio K, Ishida Y, Okada R, Goto Y, Naito M, Wakai K, Ito Y, Hamajima N (2008) Smoking and serum CA 19-9 levels according to Lewis and secretor genotypes. Int J Cancer 123(12): 2880
22. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW (2004) Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 19(2): 182-186
23. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, Canto MI, Yeo CJ, Chan DW, Goggins M (2004) Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 10(3): 860-868
24. Maithel SK, Maloney S, Winston C, Gonen M, DAngelica MI, Dematteo RP, Jarnagin WR, Brennan MF, Allen PJ (2008) Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol 15(12): 3512
25. Malik G, Ward MD, Gupta SK, Trosset MW, Grizzle WE, Adam BL, Diaz JI, Semmes OJ (2005) Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 11(3): 1073
26. Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M (2009) Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med 47(6): 713
27. Ng TW, Chan DC, Barrett PH, Watts GF (2010) Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome. Clin Sci (Lond) 118(1): 79
28. Onat A, Hergenc G, Ayhan E, Ugur M, Can G (2009) Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks. Clin Chem Lab Med 47(11): 1389
29. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H, Yasui W (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64(7): 2397-2405
30. Pine JK, Fusai KG, Young R, Sharma D, Davidson BR, Menon KV, Rahman SH (2009) Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol 35(6): 605
31. Ricci F, Kern SE, Hruban RH, Iacobuzio-Donahue CA (2005) Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype. Cancer Biol Ther 4(3): 302
32. Scarlett CJ, Smith RC, Saxby A, Nielsen A, Samra JS, Wilson SR, Baxter RC (2006) Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology 130(6): 1670-1678
33. Sobin L (2009) TNM Classification of Malignant Tumours. Wiley-Blackwell: Hoboken, NJ
34. Stein O, Dabach Y, Hollander G, Ben-Naim M, Oette K, Stein Y (1995) Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture. Biochim Biophys Acta 1257(2): 174
35. Tacikowski T, Milewski B, Dzieniszewski J, Nowicka G, Walewska-Zielecka B (2000) Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis. Med Sci Monit 6(2): 325
36. Takano S, Yoshitomi H, Togawa A, Sogawa K, Shida T, Kimura F, Shimizu H, Tomonaga T, Nomura F, Miyazaki M (2008) Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells. Oncogene 27(20): 2810
37. Wang F, Kumagai-Braesch M, Herrington MK, Larsson J, Permert J (2009) Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system. Metabolism 58(8): 1131
38. Wang YY, Cheng P, Chan DW (2003) A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis. Proteomics 3(3): 243-248
39. Xue A, Xue M, Jackson C, Smith RC (2009) Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol 41(8-9): 1731
40. Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ (2005) Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 68(1): 79-86